Choose Site

Conferences and Speeches

In-House Counsel and Pricing Executive Forum on Government Regulation of Prescription Drug Pricing

Monday, June 23, 2014 {ml-event-to} Tuesday, June 24, 2014
01:00 AM ET

Strategies for Effective Negotiations with PBMs: Understanding the Current State of the Law and Anticipated Legal and Policy Changes that May Impact Data Transfer and Transparency Requirements

Please join Morgan Lewis partner Andrew Ruskin for a one hour presentation to discuss advanced strategies for Counsel and their Government pricing clients on Medicaid and Medicare pricing and reimbursement including:

  • Positioning your company to best negotiate with PBMs
    • Comprehending the PBM mindset and criteria for deal-making
  • Transparency and PBMs: lessons for drug manufacturers
    • Forced PBM transparency under Part D
    • Effect of Corporate Drug- Purchasing Coalition transparency
  • What are the ramifications of making data available beyond the government?
  • Overcoming the explosion of FCA cases due to the analysis and use of data by the government
    • What are the ramifications of making data available beyond the government?
  • Devising strategies for PBMs to respond to the challenges of new and proposed rules and data sets being release within a five month period
  • Techniques for ensuring firewalls when working with PBMs that have Federal healthcare program business and commercial business
  • Understanding the relationship between the PBM and its customers, and the implications of the Anti-Kickback Statute and False Claims Act to those relationships

when
Monday, June 23, 2014
4:15 pm–5:15 pm

where
The Carlton Hotel
New York, NY